Cosmetic Procedure & Injectable Treatment Note

Consent & Pre-Procedure Details Patient gave full verbal and written consent for the procedure, confirming understanding of the process. Screening for Body Dysmorphic Disorder (BDD) was negative. Patient explicitly consented to the use of AI in documentation. All details regarding the procedure, including potential outcomes and risks, were thoroughly discussed and accepted. Discussion involved a detailed breakdown of the treatment plan for wrinkle reduction using dermal fillers. Benefits highlighted included improved facial aesthetics and a more youthful appearance. Risks such as bruising, swelling, and rare allergic reactions were reviewed. Alternative treatments, including neurotoxin injections and surgical options, were also presented. Patient confirmed understanding and agreement with the proposed plan. Procedures for dermal filler injection into the nasolabial folds and marionette lines were clearly explained. Patient confirmed all questions regarding the procedure, aftercare, and potential side effects had been comprehensively answered. No outstanding issues or concerns were identified. Cost of procedure: £450 Key points discussed: Treatment goals were centred on softening deep lines around the mouth to achieve a more rested and natural look. Expected results included a visible reduction in wrinkle depth, with full effects appearing within 2 weeks. Longevity of the filler was estimated to be 9-12 months. Downtime was explained as minimal, typically involving mild swelling or bruising for 24-48 hours. Changes in medications or health concerns: Patient reported no new medications since the initial consultation. No new health concerns were identified that would contraindicate the procedure. Patient confirmed they are not currently pregnant or breastfeeding. Content of discussion: The discussion focused on the anticipated progress post-injection, immediate aftercare instructions, and signs of potential side effects to monitor. Management plans for common post-procedure effects were detailed. No new technologies were discussed during this session. Products Used – Product name: Juvederm Voluma – Volume (mL): 1.0 – Batch number: JVD87654321 – REF: AESTH-102 – Expiry date: 1 November 2025 Procedure Details & Summary – Aseptic technique: Standard aseptic technique observed, including hand sanitisation, sterile gloves, and skin preparation with chlorhexidine. – Safety checks: Patient identification confirmed, consent verified, product integrity checked (expiry date, batch number), and contraindications reviewed prior to injection. – Procedure description: Dermal filler (Juvederm Voluma) was injected into the nasolabial folds using a fanning technique with a 27G cannula, administering 0.5mL per side. The marionette lines were treated with serial puncture using a 30G needle, administering 0.25mL per side. Product was distributed evenly to ensure a smooth result. – Tolerance: Patient tolerated the procedure well with minimal discomfort, managed with topical anaesthetic. No immediate complications such as excessive bruising or allergic reaction observed. – Aftercare: Aftercare instructions provided verbally and in writing included avoiding strenuous exercise for 24 hours, refraining from touching the treated area for 6 hours, applying a cold compress for swelling, and advising to contact the clinic immediately for any signs of infection or vascular compromise (e.g., severe pain, discolouration). Red-flag symptoms were clearly explained. – Follow-up: A follow-up appointment was scheduled for 2 weeks to assess results and address any concerns. History of Presenting Complaint (HPC) Patient presented for their scheduled dermal filler treatment to address concerns regarding prominent nasolabial folds and marionette lines, which they felt made them appear tired and older. This is a continuation of their aesthetic journey, following a previous successful treatment 10 months prior. Past Medical History Patient has no significant past medical history. Previous cosmetic treatments include neurotoxin injections to the glabella 6 months ago, with good results and no complications. No ongoing medical conditions or relevant disorders were reported. Medications and Allergies Current medications & supplements: Multivitamin daily, no prescription medications. Allergies: Penicillin (rash), no known allergies to aesthetic products. Family History No significant family history of autoimmune diseases or adverse reactions to cosmetic procedures. Family history includes hypertension in maternal grandmother. Session Content The session primarily focused on the safe and effective administration of dermal fillers. Patient expressed satisfaction with previous treatments and had realistic expectations for the current procedure. Discussions included the physiological effects of hyaluronic acid fillers, potential minor side effects such as temporary swelling and bruising, and the management plan for optimal recovery. Examination findings confirmed the suitability of the areas for treatment. The agreed-upon procedures for nasolabial folds and marionette lines were carried out as planned. Plan for Next Session Next appointment: 15 November 2024 Plan for next session is to review the results of the current dermal filler treatment, assess patient satisfaction, and evaluate the longevity of the product. Specific attention will be given to the symmetry and smoothness of the treated areas. Further discussions regarding future aesthetic goals or potential touch-ups will occur if desired by the patient.